Plasma Rich in Growth Factors (PRGF-Endoret) in the Regeneration of Post-Extraction Sockets
Launched by FUNDACIÓN EDUARDO ANITUA · Nov 2, 2011
Trial Information
Current as of April 25, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • subjects of both genders and ≥ 18 years old
- • Indication of a simple one molar extraction in the mandible.
- • Possibility of observation during the follow-up period.
- Exclusion Criteria:
- • Unerupted third molars or with horizontal inclination.
- • Severe swelling prior to surgery in the areas designated for extraction.
- • Suffering an alteration or a serious hematologic disease.
- • Be currently undergoing or have received radiotherapy, chemotherapy or immunosuppressive therapy, corticosteroids and/or anticoagulants 30 days prior to inclusion
- • In regular treatment with NSAIDs or other anti-inflammatory drugs.
- • History of chronic hepatitis or cirrhosis.
- • Diabetes mellitus with poor metabolic control (glycosylated hemoglobin \>9%)
- • Patients undergoing dialysis.
- • Presence of malignant tumors, hemangiomas or angiomas in the extraction area.
- • History of ischemic heart disease in the last year.
- • Pregnancy or planned pregnancy during the study follow-up period.
- • Metabolic Bone Disease.
- • Patients taking bisphosphonates both orally and intravenously.
- • In general, any inability to participate in the study.
About Fundación Eduardo Anitua
Fundación Eduardo Anitua is a prominent clinical research organization dedicated to advancing medical science through rigorous investigation and innovation. With a focus on the fields of regenerative medicine and tissue engineering, the foundation conducts a range of clinical trials aimed at developing novel therapeutic solutions. By fostering collaboration among leading researchers, healthcare professionals, and academic institutions, Fundación Eduardo Anitua strives to translate groundbreaking research into effective treatments that improve patient outcomes and enhance quality of life. Committed to ethical standards and scientific excellence, the foundation plays a vital role in shaping the future of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vitoria, , Spain
Patients applied
Trial Officials
Eduardo Anitua, MD, DDS, PhD
Study Director
Clinica Dental Eduardo Anitua
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials